how were glp 1 agonists discovered Discovery of Biased Dual-Agonists of Glucagon-Like Peptide and Glucagon Receptors through Mutation of a Conserved Aspartate How do GLP-1 agonists affect

However, the expression of GLP-1R in liver tissue remains controversial

Le Roux CA, Steen O, Lucas KJ, Startseva E, Unseld A, Hennige AM

Nauck MA, Niedereichholz U, Ettler R, et al

Key protective strategies include: Pre-treatment ophthalmologic evaluation : Establish baseline retinal status before initiating GLP-1 therapy, particularly in patients with diabetes duration exceeding 10 years or poor prior glycemic control Individualized medication titration : Consider a more gradual dose escalation approach to avoid precipitous drops in blood glucose for patients with advanced diabetic retinopathy, in coordination with ophthalmology care Appropriate monitoring : Discuss with your healthcare provider whether more frequent eye examinations are needed based on your individual risk factors and baseline retinal status Prompt reporting of visual symptoms : Contact your healthcare provider immediately if you experience sudden vision loss, new or dense floaters, flashing lights, a "curtain" over your vision, eye pain with vision changes, or any sudden vision disturbance Patients without pre-existing diabetic retinopathy can generally follow standard eye examination schedules and do not require additional ophthalmologic monitoring solely due to GLP-1 use

Safety Overall, 9 (69.2%) patients treated with GLP-1-RAs reported at least one AE

Also, microribonucleic acid (RNA) (miRNAs), critical regulators of gene expression, are introduced as potential modulators of GLP-1 signaling